Healthcare Profit Motives

Brigham highlights the alarming disparity in insulin pricing, revealing that pharmaceutical companies receive a fraction of the cost while pharmacy benefit managers and insurance companies pocket the rest. He emphasizes the misconception surrounding health insurance, clarifying that what many have is actually a managed care plan designed to profit from patient treatment. Recent findings in Ohio expose significant fraud within pharmacy benefit managers, showcasing the layers of financial manipulation that plague the healthcare system.